Key Events This Week
11 May: New 52-week high at Rs.2,197
12 May: Sharp profit decline reported in Q4 FY26 results
12 May: Technical momentum shifts to bullish amid strong price gains
15 May: Week closes at Rs.2,137.15 (-0.69%)

J B Chemicals & Pharmaceuticals Ltd is Rated Hold
2026-05-14 10:10:03J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read full news articleAre J B Chemicals & Pharmaceuticals Ltd latest results good or bad?
2026-05-12 19:15:29J B Chemicals & Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal significant challenges, particularly in terms of profitability and sales performance. The company reported a net profit of ₹101.37 crore, which reflects a notable sequential decline of 48.77% from the previous quarter and a year-on-year decrease of 30.42%. This sharp drop in profit raises concerns about the sustainability of the company's earnings. Net sales for the same quarter amounted to ₹904.23 crore, marking a sequential decline of 15.07% from ₹1,064.72 crore in Q3 FY26 and a year-on-year decrease of 4.77%. This decline in revenue indicates potential cyclical and structural challenges within the business, as it represents the lowest quarterly revenue in FY26. The operating profit margin, excluding other income, contracted to 22.24%, down from 27.78% in the previous quarter, indicating significant margin compression. Thi...
Read full news article
J B Chemicals Q4 FY26: Sharp Profit Decline Amid Margin Pressure Raises Concerns
2026-05-12 16:46:45J B Chemicals & Pharmaceuticals Ltd. reported a concerning Q4 FY26 performance, with net profit plunging 48.77% quarter-on-quarter to ₹101.37 crores and declining 30.42% year-on-year. The sharp contraction in profitability, coupled with sequential revenue decline of 15.07% to ₹904.23 crores, has raised red flags about the company's operational momentum. Following the results announcement, shares traded at ₹2,133.80 on May 12, 2026, down 3.35% from the previous close, reflecting investor disappointment with the pharmaceutical manufacturer's performance.
Read full news article
J B Chemicals & Pharmaceuticals Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains
2026-05-12 08:03:13J B Chemicals & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The stock’s recent performance, coupled with upgrades in its technical trend and a revised Mojo Grade, signals renewed investor interest amid a challenging market backdrop.
Read full news article
Broad-Based Technical Strength Lifts J B Chemicals & Pharmaceuticals Ltd to 52-Week High of Rs 2197
2026-05-11 11:10:08Surging to a fresh 52-week high of Rs 2197 on 11 May 2026, J B Chemicals & Pharmaceuticals Ltd has demonstrated robust price momentum, outperforming its sector and the broader market despite a declining Sensex. The stock’s six-day consecutive gain, delivering a 7.27% return in that span, underscores a sustained technical uptrend that has propelled it well above key moving averages.
Read full news article







